P62 at the interface of autophagy, oxidative stress signaling, and cancer

Antioxidants and Redox Signaling

Volumn 17, Issue 5, 2012, Pages 786-793

  Nezis, Ioannis P ^a,b   Stenmark, Harald ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

KELCH LIKE ECH ASSOCIATED PROTEIN 1; MUTANT PROTEIN; PROTEIN P62; SEQUESTOSOME 1; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

AUTOPHAGY; CARCINOGENESIS; HUMAN; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

AUTOPHAGY; HUMANS; NEOPLASMS; OXIDATIVE STRESS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 84863425313     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4394     Document Type: Review

References (46)

1. Avila A, Silverman N, Diaz-Meco MT, and Moscat J. The Drosophila atypical protein kinase C-ref(2)p complex constitutes a conserved module for signaling in the toll pathway. Mol Cell Biol 24: 8787-8795, 2002. (Pubitemid 35397191)
2. Bjørkøy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H, and Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171: 603-614, 2005. (Pubitemid 41668720)
3. Carré-Mlouka A, Gaumer S, Gay P, Petitjean AM, Coulondre C, Dru P, Bras F, Dezélée S, and Contamine D. Control of sigma virus multiplication by the ref(2)P gene of Drosophila melanogaster: an in vivo study of the PB1 domain of Ref(2)P. Genetics 176: 409-419, 2007. (Pubitemid 350021036)
4. Copple IM, Lister A, Obeng AD, Kitteringham NR, Jenkins RE, Layfield R, Foster BJ, Goldring CE, and Park BK. Physical and functional interaction of sequestosome 1 with KEAP1 regulates the KEAP1-NRF2 cell defense pathway. J Biol Chem 285: 16782-16788, 2010.
5. DeNicola GM, Karreth FA, Humpton TJ, Gopinathan A, Wei C, Frese K, Mangal D, Yu KH, Yeo CJ, Calhoun ES, Scrimieri F, Winter JM, Hruban RH, Iacobuzio-Donahue C, Kern SE, Blair IA, and Tuveson DA. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475: 106-109, 2011.
6. Durán A, Serrano M, Leitges M, Flores JM, Picard S, Brown JP, Moscat J, and Diaz-Meco MT. The atypical PKCinteracting protein p62 is an important mediator of RANKactivated osteoclastogenesis. Dev Cell 6: 303-309, 2004. (Pubitemid 38190368)
7. Durán A, Linares JF, Galvez AS, Wikenheiser K, Flores JM, Diaz-Meco MT, and Moscat J. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell 13: 343-354, 2008. (Pubitemid 351446193)
8. Fan W, Tang Z, Chen D, Moughon D, Ding X, Chen S, Zhu M, and Zhong Q. KEAP1 facilitates p62-mediated ubiquitin aggregate clearance via autophagy. Autophagy 6: 614-621, 2010.
9. Gavet O and Pines J. Activation of cyclin B1-Cdk1 synchronizes events in the nucleus and the cytoplasm at mitosis. J Cell Biol 189: 247-259, 2010.
10. Jain A, Lamark T, Sjøttem E, Larsen KB, Awuh JA, Øvervatn A, McMahon M, Hayes JD, and Johansen T. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 285: 22576-22591, 2010.
11. Jin Z, Li Y, Pitti R, Lawrence D, Pham VC, Lill JR, and Ashkenazi A. Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8 mediate extrinsic apoptosis signaling. Cell 137: 721-735, 2009.
12. Johansen T and Lamark T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 7: 279-296, 2011.
13. Goto A, Blandin S, Royet J, Reichhart JM, and Levashina EA. Silencing of Toll pathway components by direct injection of double-stranded RNA into Drosophila adult flies. Nucleic Acids Res 22: 6619-6623, 2003. (Pubitemid 37508768)
14. Ichimura Y, Kumanomidou T, Sou YS, Mizushima T, Ezaki J, Ueno T, Kominami E, Yamane T, Tanaka K, and Komatsu M. Structural basis for sorting mechanism of p62 in selective autophagy. J Biol Chem 283: 22847-22857, 2008.
15. Inami Y, Waguri S, Sakamoto A, Kouno T, Nakada K, Hino O, Watanabe S, Ando J, Iwadate M, Yamamoto M, Lee MS, Tanaka K, and Komatsu M. Persistent activation of NRF2 through p62 in hepatocellular carcinoma cells. J Cell Biol 193: 275-284, 2011.
16. Itakura E and Mizushima N. p62 targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding. J Cell Biol 192: 17-27, 2011.
17. Itoh K, Tong KI, and Yamamoto M. Molecular mechanism activating NRF2-KEAP1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med 36: 1208-1213, 2004. (Pubitemid 38526314)
18. Kobayashi M, Li L, Iwamoto N, Nakajima-Takagi Y, Kaneko H, Nakayama Y, Eguchi M, Wada Y, Kumagai Y, and Yamamoto M. The antioxidant defense system KEAP1-NRF2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol Cell Biol 29: 493-502, 2009.
19. Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI, Kim M, Nishito Y, Iemura S, Natsume T, Ueno T, Kominami E, Motohashi H, Tanaka K, and Yamamoto M. The selective autophagy substrate p62 activates the stress responsive transcription factor NRF2 through inactivation of KEAP1. Nat Cell Biol 12: 213-223, 2010.
20. Lau A, Wang XJ, Zhao F, Villeneuve NF, Wu T, Jiang T, Sun Z, White E, and Zhang DD. A noncanonical mechanism of NRF2 activation by autophagy deficiency: direct interaction between KEAP1 and p62. Mol Cell Biol 30: 3275-3285, 2010.
21. Laurin N, Brown JP, Morissette J, and Raymond V. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 70: 1582-1588, 2002. (Pubitemid 34533906)
22. Lee DF, Kuo HP, Liu M, Chou CK, Xia W, Du Y, Shen J, Chen CT, Huo L, Hsu MC, Li CW, Ding Q, Liao TL, Lai CC, Lin AC, Chang YH, Tsai SF, Li LY, and Hung MC. KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta. Mol Cell 36: 131-140, 2009.
23. Lee SJ, Pfluger PT, Kim JY, Nogueiras R, Duran A, Pages G, Pouyssegur J, Tschoep MH, Diaz-Meco MT, and Moscat J. A functional role for the p62-ERK1 axis in the control of energy homeostasis and adipogenesis. EMBO Rep 11: 226-232, 2010.
24. Linares JF, Amanchy R, Greis K, Diaz-Meco MT, and Moscat J. Phosphorylation of p62 by cdk1 controls the timely transit of cells through mitosis and tumor cell proliferation. Mol Cell Biol 31: 105-117, 2011.
25. Lo SC and Hannink M. PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex. J Biol Chem 281: 37893-37903, 2006. (Pubitemid 46042093)
26. Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C, Dipaola RS, Karantza-Wadsworth V, and White E. Autophagy suppresses tumorigenesis through elimination of p62. Cell 137: 1062-1075, 2009.
27. McMahon M, Thomas N, Itoh K, Yamamoto M, and Hayes JD. Dimerization of substrate adaptors can facilitate cullinmediated ubiquitylation of proteins by a "tethering" mechanism: a two-site interaction model for the NRF2-KEAP1 complex. J Biol Chem 281: 24756-24768, 2006. (Pubitemid 44274250)
28. Moscat J and Diaz-Meco MT. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 137: 1001-1004, 2009.
29. Moscat J, Diaz-Meco MT, and Wooten MW. Of the atypical PKCs, Par-4 and p62: recent understandings of the biology and pathology of a PB1-dominated complex. Cell Death Differ 16: 1426-1437, 2009.
30. Narendra D, Kane LA, Hauser DN, Fearnley IM, and Youle RJ. p62/SQSTM1 is required for Parkin-induced mitochondrial clustering but not mitophagy; VDAC1 is dispensable for both. Autophagy 6: 1090-1106, 2010.
31. Nezis IP, Simonsen A, Sagona AP, Finley K, Gaumer S, Contamine D, Rusten TE, Stenmark H, and Brech A. Ref(2)P, the Drosophila melanogaster homologue of mammalian p62, is required for the formation of protein aggregates in adult brain. J Cell Biol 180: 1065-1071, 2008. (Pubitemid 351468465)
32. Ohta T, Iijima K, Miyamoto M, Nakahara I, Tanaka H, Ohtsuji M, Suzuki T, Kobayashi A, Yokota J, Sakiyama T, Shibata T, Yamamoto M, and Hirohashi S. Loss of KEAP1 function activates NRF2 and provides advantages for lung cancer cell growth. Cancer Res 68: 1303-1309, 2008. (Pubitemid 351346836)
33. Padmanabhan B, Tong KI, Ohta T, Nakamura Y, Scharlock M, Ohtsuji M, Kang MI, Kobayashi A, Yokoyama S, and Yamamoto M. Structural basis for defects of KEAP1 activity provoked by its point mutations in lung cancer. Mol Cell 21: 689-700, 2006. (Pubitemid 43290735)
34. Pan JA, Ullman E, Dou Z, and Zong WX. Inhibition of protein degradation induces apoptosis through a microtubuleassociated protein 1 light chain 3-mediated activation of caspase-8 at intracellular membranes. Mol Cell Biol 31: 3158-3170, 2011.
35. Pankiv S, Lamark T, Bruun JA, Øvervatn A, Bjørkøy G, and Johansen T. Nucleocytoplasmic shuttling of p62/SQSTM1 and its role in recruitment of nuclear polyubiquitinated proteins to promyelocytic leukemia bodies. J Biol Chem 285: 5941-5953, 2010.
36. Ramesh Babu J, Lamar Seibenhener M, Peng J, Strom AL, Kemppainen R, Cox N, Zhu H, Wooten MC, Diaz-Meco MT, Moscat J, and Wooten MW. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J Neurochem 106: 107-120, 2008. (Pubitemid 351840194)
37. Rodriguez A, Durán A, Selloum M, Champy MF, Diez-Guerra FJ, Flores JM, Serrano M, Auwerx J, Diaz-Meco MT, and Moscat J. Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. Cell Metab 3: 211-222, 2006.
38. Sanz L, Diaz-MecoMT, Nakano H, andMoscat J. The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway. EMBO J 19: 1576-1586, 2000. (Pubitemid 30182165)
39. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, and Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26: 1749-1760, 2007. (Pubitemid 46624042)
40. Shibata T, Ohta T, Tong KI, Kokubu A, Odogawa R, Tsuta K, Asamura H, Yamamoto M, and Hirohashi S. Cancer related mutations in NRF2 impair its recognition by KEAP1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci USA 105: 13568-13573, 2008.
41. Shibata T, Kokubu A, Gotoh M, Ojima H, Ohta T, Yamamoto M, and Hirohashi S. Genetic alteration of KEAP1 confers constitutive NRF2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 135: 1358-1368, 2008.
42. Singh A, Misra V, Thimmulappa RK, Lee H, Ames S, Hoque MO, Herman JG, Baylin SB, Sidransky D, Gabrielson E, Brock MV, and Biswal S. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med 3: e420, 2006.
43. Taguchi K, Motohashi H, and Yamamoto M. Molecular mechanisms of the KEAP1-NRF2 pathway in stress response and cancer evolution. Genes Cells 16: 123-140, 2011.
44. Takamura A, Komatsu M, Hara T, Sakamoto A, Kishi C, Waguri S, Eishi Y, Hino O, Tanaka K, and Mizushima N. Autophagy-deficient mice develop multiple liver tumors. Genes Dev 25: 795-800, 2011.
45. Watanabe Y and Tanaka M. p62/SQSTM1 in autophagic clearance of a non-ubiquitilated substrate. J Cell Sci 124: 2692-2701, 2011.
46. Yang Z and Klionsky DJ. Eaten alive: a history of macroautophagy. Nat Cell Biol 12: 814-822, 2010.